Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,231,742 papers from all fields of science
Search
Sign In
Create Free Account
Ergot preparation
Known as:
ERGOT
, ergots
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Amprenavir
Angina Pectoris, Variant
Cerebral Arterial Vasoconstriction [PE]
Drug Allergy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron
,
P. Lucas
,
Joshua Eades
,
O. Hogue
The journal of headache and pain
2018
Corpus ID: 44135778
BackgroundMedicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to…
Expand
2011
2011
Delivery Outcome after Maternal Use of Drugs for Migraine
B. Källén
,
E. Nilsson
,
P. O. Olausson
Drug safety
2011
Corpus ID: 1277564
AbstractBackground: The use of drugs for migraine during pregnancy may have adverse effects on delivery outcome, and warnings…
Expand
Highly Cited
2003
Highly Cited
2003
Rates and predictors for relapse in medication overuse headache: A 1-year prospective study
Z. Katsarava
,
V. Limmroth
,
M. Finke
,
H. Diener
,
G. Fritsche
Neurology
2003
Corpus ID: 22923813
The authors prospectively studied 98 patients with medication overuse headache. The 1-year relapse rate was 38% but was lower for…
Expand
Review
2003
Review
2003
Ergotamine and dihydroergotamine: A review
M. Bigal
,
S. Tepper
Current pain and headache reports
2003
Corpus ID: 23124461
The ergot alkaloids were the first specific antimigraine therapy available. However, with the advent of the triptans, their use…
Expand
Highly Cited
2002
Highly Cited
2002
Features of medication overuse headache following overuse of different acute headache drugs
V. Limmroth
,
Z. Katsarava
,
G. Fritsche
,
S. Przywara
,
H. Diener
Neurology
2002
Corpus ID: 23156420
ObjectiveTo investigate pharmacologic features such as mean critical duration until onset of medication-overuse headache (MOH…
Expand
Highly Cited
2001
Highly Cited
2001
Clinical features of withdrawal headache following overuse of triptans and other headache drugs
Z. Katsarava
,
G. Fritsche
,
M. Muêssig
,
H. Diener
,
V. Limmroth
Neurology
2001
Corpus ID: 41046350
Background: Complete withdrawal from headache medication is the treatment of choice for medication-overuse headache…
Expand
Highly Cited
1993
Highly Cited
1993
Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis.
T. Endo
,
R. Aten
,
F. Wang
,
H. Behrman
Endocrinology
1993
Corpus ID: 12664208
Structural luteolysis was found decades ago to be induced by PRL in the hypophysectomized rat, but the mechanisms of this process…
Expand
1962
1962
The obstetrical use of ergot: a violation of the doctrine "primum non nocere".
R. Ca
1962
Corpus ID: 57836215
Highly Cited
1935
Highly Cited
1935
THE SUBSTANCE RESPONSIBLE FOR THE TRADITIONAL CLINICAL EFFECT OF ERGOT
H. W. Dudley
,
C. Moir
British medical journal
1935
Corpus ID: 42792284
a suprarenal cortex, and only occasionally to a malignant tumour. Not infrequently hyperplasia or neoplasia (adenoma) of the pars…
Expand
Highly Cited
1932
Highly Cited
1932
THE ACTION OF ERGOT PREPARATIONS ON THE PUERPERAL UTERUS
C. Moir
,
H. Dale
British medical journal
1932
Corpus ID: 38152173
division, this being justified by the issues at stake. The whole operation was done through one cannula. A direct vision…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE